Literature DB >> 30095558

Three-Dimensional High-Resolution Black-Blood Magnetic Resonance Imaging for Detection of Arteritic Anterior Ischemic Optic Neuropathy in Patients With Giant Cell Arteritis.

Nora N Sommer, Karla M Treitl1, Eva Coppenrath, Hendrik Kooijman2, Claudia Dechant3, Michael Czihal4, Theresa M Kolben5, Sebastian E Beyer, Wieland H Sommer, Tobias Saam6.   

Abstract

OBJECTIVES: Arteritic anterior ischemic optic neuropathy (A-AION) caused by inflammatory occlusion of the posterior ciliary arteries is the most common reason for irreversible vision loss in patients with giant cell arteritis. Atypical clinical presentation and negative funduscopy can delay systemic high-dose corticosteroid therapy to prevent impending permanent blindness and involvement of the contralateral eye.The purpose of this study was to assess the diagnostic accuracy of 3-dimensional (3D) high-resolution T1-weighted black-blood magnetic resonance imaging (T1-BB-MRI) for the detection of posterior ciliary artery involvement in patients with giant cell arteritis and funduscopic A-AION.
MATERIALS AND METHODS: After institutional review board approval and informed consent, 27 patients with suspected giant cell arteritis and vision disturbances were included in this monocentric prospective cohort study. Giant cell arteritis was diagnosed in 18 patients according to the diagnostic reference standard (6 men, 73.8 [69.0-78.0] years); 14 of those were positive for A-AION. Precontrast and postcontrast 3D T1-BB-MRI was performed in all 27 patients. Two radiologists separately assessed image quality and local fat suppression (4-point scale), visual contrast enhancement (3-point scale), and diagnostic confidence (5-point scale) regarding arteritic posterior ciliary artery involvement. Magnetic resonance imaging findings were assessed in comparison to funduscopy. Statistical analysis included accuracy parameters and interrater agreement.
RESULTS: Sensitivity of 3D T1-BB-MRI was 92.9% (95% confidence interval, 66.1%-99.8%) and specificity was 92.3% (95% confidence interval, 64.0%-99.8%) for detection of A-AION-positive patients. Image quality and local fat suppression were assessed with 3.2 ± 0.8 (median 3) and 3.8 ± 0.5 (median 4). Visual contrast enhancement with 2.3 ± 0.8 (median 3) and diagnostic confidence was rated at 4.7 ± 0.5 (median 5). Interrater agreement was high (κ = 0.85, P < 0.001). Three-dimensional T1-BB-MRI displayed bilateral findings in 50% of the cases, whereas only unilateral A-AION was detected in funduscopy as a possible indication for the contralateral eye at risk.
CONCLUSIONS: Three-dimensional T1-BB-MRI allows accurate detection of arteritic posterior ciliary artery involvement in patients with A-AION. Further, 3D T1-BB-MRI seems to display arteritic involvement of the posterior ciliary arteries earlier than funduscopy and might, therefore, display "vision-at-risk" in patients with visual impairment and suspected giant cell arteritis but unremarkable funduscopy.

Entities:  

Mesh:

Year:  2018        PMID: 30095558     DOI: 10.1097/RLI.0000000000000500

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  6 in total

1.  3D black-blood 3T-MRI for the diagnosis of abdominal large vessel vasculitis.

Authors:  Stefan Maurus; Nora N Sommer; Hendrik Kooijman; Eva Coppenrath; Matthias Witt; Hendrik Schulze-Koops; Michael Czihal; Ulrich Hoffmann; Tobias Saam; Karla M Treitl
Journal:  Eur Radiol       Date:  2019-09-16       Impact factor: 5.315

2.  High-resolution MRI demonstrates signal abnormalities of the 3rd cranial nerve in giant cell arteritis patients with 3rd cranial nerve impairment.

Authors:  Sandy Mournet; Thomas Sené; Frédérique Charbonneau; Guillaume Poillon; Catherine Vignal; Gaëlle Clavel; Kévin Zuber; Julien Savatovsky; Augustin Lecler
Journal:  Eur Radiol       Date:  2021-01-13       Impact factor: 5.315

Review 3.  SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.

Authors:  Tim Leiner; Jan Bogaert; Matthias G Friedrich; Raad Mohiaddin; Vivek Muthurangu; Saul Myerson; Andrew J Powell; Subha V Raman; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2020-11-09       Impact factor: 5.364

Review 4.  Vessel wall MR imaging in neuroradiology.

Authors:  Yasutaka Fushimi; Kazumichi Yoshida; Masakazu Okawa; Takakuni Maki; Satoshi Nakajima; Akihiko Sakata; Sachi Okuchi; Takuya Hinoda; Mitsunori Kanagaki; Yuji Nakamoto
Journal:  Radiol Med       Date:  2022-07-30       Impact factor: 6.313

5.  Utility of standard diffusion-weighted magnetic resonance imaging for the identification of ischemic optic neuropathy in giant cell arteritis.

Authors:  L A Danyel; M Miszczuk; C Pietrock; B T Büge; K Villringer; G Bohner; E Siebert
Journal:  Sci Rep       Date:  2022-10-03       Impact factor: 4.996

6.  Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements.

Authors:  Rosanna Dammacco; Giovanni Alessio; Ermete Giancipoli; Patrizia Leone; Anna Cirulli; Leonardo Resta; Angelo Vacca; Franco Dammacco
Journal:  Clin Ophthalmol       Date:  2020-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.